Clinical Trials
3 trialsNCT07619339 2026-06-02
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT05782361 2026-04-24
POTENT
Institute of Cancer Research, United Kingdom
Phase 1 Active not recruiting
NCT05120960 2024-04-17
A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
M.D. Anderson Cancer Center
Phase 1 Withdrawn